| Financial Year |
March 31 2023 |
| Monetary Funds |
1,568,526,020.29 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
5,353,800.00 |
| Advances to Suppliers |
18,594,538.41 |
| Other Receivables |
16,936,460.04 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
2,449,050,670.99 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
11,230,855.32 |
| Total Current Assets |
4,069,692,345.05 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
8,891,391.64 |
| Fixed Assetes |
474,598,952.94 |
| Under-construction Projects |
1,796,901,939.33 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
167,315,014.87 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
13,221,080.26 |
| Deferred Income Tax Assets |
337,796,491.76 |
| Other Non-Current Assets |
24,393,603.59 |
| Sub-Total of Non-Current Assets |
2,832,790,396.56 |
| Total Assets |
6,902,482,741.61 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
17,854,178.36 |
| Accounts Payable |
1,001,272,286.24 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
105,869,960.56 |
| Taxes Payable |
154,206,185.47 |
| Interest Payable |
-- |
| Dividend Payable |
520,865,810.29 |
| Other payables |
936,642,631.59 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
6,212,740.19 |
| Other Current Liabilities |
31,356,772.71 |
| Sub-Total of Current Liabilities |
3,251,393,761.90 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
22,075,227.22 |
| Sub-Total of Non-Current Liabilities |
26,956,793.41 |
| Total Liabilities |
3,278,350,555.31 |
| Paid-In Capital(Or Share Stock) |
488,361,398.00 |
| Capital Surplus |
424,720,700.33 |
| Surplus Reserve |
410,573,087.70 |
| LESS:Treasury Stock |
172,221,298.12 |
| Undistributed Profits |
2,472,698,298.39 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,624,132,186.30 |
| Owner's Equity（Stockholder's Equity） |
3,624,132,186.30 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
6,902,482,741.61 |
